Home Markets Regeneron slides as Amgen wins Eylea biosimilar case; RBC still bullish

Regeneron slides as Amgen wins Eylea biosimilar case; RBC still bullish

Andrew M Sep 24, 2024 comments off

Original source: https://www.investing.com/news/stock-market-news/regeneron-slides-as-amgen-wins-eylea-biosimilar-case-rbc-still-bullish-3628943

Amgen Market Updates REGENERON www.investing.com/news/stock-market-news/regeneron-slides-as-amgen-wins-eylea-biosimilar-case-rbc-still-bullish-3628943